Neuroscience and Behavior Program, University of Massachusetts, Amherst, Massachusetts 01003, USA.
Synapse. 2010 Jun;64(6):421-31. doi: 10.1002/syn.20744.
We have recently shown that chronic intermittent exposure of adolescent rats to 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) completely blocks the reduction in serotonin transporter (SERT) binding and the hypoactivity seen following a subsequent MDMA binge treatment. The present study determined whether a similar neuroprotective effect also occurs in rats given the same intermittent MDMA exposure in adulthood. Adult male Sprague-Dawley rats were given either MDMA (10 mg/kg x 2) or saline, every fifth day, from postnatal day (PD) 60 to PD 85. The MDMA-induced latency until seminal plug production was reduced over the course of intermittent treatments. After a 1-week wash-out period, animals received either a low- or high-dose MDMA binge (2.5 or 5.0 mg/kg x 4). Core body temperature was measured during and after the binge to determine the effects of MDMA pretreatment on MDMA-induced hyperthermia. Spontaneous motor activity was determined the next day, and cortical and hippocampal samples were collected at 1 week postbinge to measure serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations as well as [3H]citalopram binding to SERT. Hyperthermia occurred more rapidly and seminal discharge was more common in the MDMA-pretreated group compared to the MDMA-naïve group in animals given the low-dose binge. MDMA preexposure protected animals from the reductions in cortical 5-HT levels and SERT binding produced by the high-dose binge and blocked the postbinge hypoactivity. These findings indicate that chronic, intermittent MDMA exposure in adulthood induces neuroprotective effects similar to those seen with adolescent treatment. However, there was also evidence for drug-induced sensitization in adults that was not observed in adolescents. Thus, altered drug sensitivity in chronic Ecstasy users may depend not only on the frequency and pattern of use but also on the age of the user.
我们最近表明,慢性间歇性暴露于青少年大鼠 3,4-亚甲基二氧甲基苯丙胺(MDMA 或摇头丸)完全阻断了随后的 MDMA 狂欢治疗后血清素转运体(SERT)结合和低活动的减少。本研究确定在给予成年大鼠相同的间歇性 MDMA 暴露时是否也会发生类似的神经保护作用。成年雄性 Sprague-Dawley 大鼠从出生后第 60 天至第 85 天,每隔 5 天接受 MDMA(10mg/kg×2)或生理盐水治疗。MDMA 诱导的精子栓产生潜伏期在间歇性治疗过程中减少。经过 1 周的洗脱期后,动物接受低剂量或高剂量 MDMA 狂欢(2.5 或 5.0mg/kg×4)。在狂欢期间和之后测量核心体温,以确定 MDMA 预处理对 MDMA 诱导的发热的影响。狂欢后第二天测定自发运动活动,并在狂欢后 1 周采集皮质和海马样本,以测量 5-羟色胺(5-HT)和 5-羟吲哚乙酸(5-HIAA)浓度以及 [3H]西酞普兰与 SERT 的结合。与 MDMA -naïve 组相比,在接受低剂量狂欢的大鼠中,MDMA 预处理组的体温升高更快,精液排出更常见。MDMA 预先暴露可防止高剂量狂欢引起的皮质 5-HT 水平降低和 SERT 结合,并阻断狂欢后低活动。这些发现表明,成年期慢性、间歇性 MDMA 暴露可诱导与青春期治疗相似的神经保护作用。然而,在成年人中也有证据表明存在药物诱导的敏感化,而在青少年中则没有观察到。因此,慢性摇头丸使用者的药物敏感性改变不仅取决于使用的频率和模式,还取决于使用者的年龄。